SPYRAL GEMINI Pilot Study
NCT06907147
This study is recruiting at 12 US sites in 10 states, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of the SPYRAL GEMINI Pilot Study is to evaluate that multi-organ denervation with the Gemini System is safe and provide evidence of blood pressure reduction when studied in an uncontrolled hypertensive population with and without high cardiovascular risk.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Hypertension
- Vascular Diseases
- Cardiovascular Diseases
- Chronic Kidney Diseases
- Diabetes Mellitus
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 18 to 80 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Medtronic Vascular
- Last updated on ClinicalTrials.gov
- June 24, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 1
- Stanford Hospital and Clinics · Stanford, CA
Florida · 2
- Orlando Health Heart & Vascular Institute · Orlando, FL
- BayCare Health System Mease Countryside Hospital · Safety Harbor, FL
Georgia · 1
- Piedmont Heart Institute · Atlanta, GA
Massachusetts · 1
- Beth Israel Deaconess Medical Center · Boston, MA
Michigan · 1
- Henry Ford Providence Hospital · Southfield, MI
Mississippi · 1
- North Mississippi Medical Center · Tupelo, MS
Nevada · 1
- Renown Regional Medical Center · Reno, NV
New Jersey · 1
- Virtua Our Lady of Lourdes Hospital · Camden, NJ
North Carolina · 1
- University of North Carolina (UNC) Memorial Hospital · Chapel Hill, NC
Texas · 2
- Baylor Heart & Vascular Hospital · Dallas, TX
- UT Health East Texas · Tyler, TX
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.